Target type: biologicalprocess
Any process that modulates the frequency, rate or extent of hepatocyte proliferation. [GOC:BHF, GOC:mah]
Hepatocyte proliferation, the process of liver cell division, is tightly regulated to maintain liver homeostasis and ensure proper regeneration after injury. This complex process involves a delicate balance of stimulatory and inhibitory signals, mediated by various growth factors, cytokines, transcription factors, and signaling pathways.
**Stimulatory Signals:**
* **Growth Factors:**
* **Hepatocyte Growth Factor (HGF):** A key mitogen for hepatocytes, promoting cell survival, proliferation, and differentiation.
* **Epidermal Growth Factor (EGF):** Stimulates hepatocyte proliferation and DNA synthesis.
* **Platelet-Derived Growth Factor (PDGF):** Involved in liver regeneration and wound healing.
* **Cytokines:**
* **Interleukin-6 (IL-6):** Activates STAT3 signaling, promoting hepatocyte survival and proliferation.
* **Tumor Necrosis Factor-alpha (TNF-alpha):** Has a complex role in liver regeneration, initially promoting inflammation and then contributing to hepatocyte proliferation.
* **Transcription Factors:**
* **c-Myc:** A master regulator of cell cycle progression, promoting G1/S transition and cell proliferation.
* **E2F1:** Plays a crucial role in G1/S transition by activating genes involved in DNA replication and cell cycle progression.
* **NF-κB:** Activated by TNF-alpha, promoting hepatocyte survival and proliferation.
**Inhibitory Signals:**
* **TGF-beta:** A potent inhibitor of hepatocyte proliferation, promoting cell cycle arrest and apoptosis.
* **Wnt/beta-catenin pathway:** Activation of this pathway can lead to cell cycle arrest and inhibition of hepatocyte proliferation.
* **p53:** A tumor suppressor gene, inducing cell cycle arrest and apoptosis in response to DNA damage, preventing uncontrolled proliferation.
* **Hippo pathway:** Regulates organ size and cell proliferation by controlling the expression of cell cycle regulators.
**Signaling Pathways:**
* **MAPK (Mitogen-Activated Protein Kinase) pathway:** Activated by growth factors, promoting cell cycle progression and proliferation.
* **PI3K/AKT pathway:** Activated by growth factors and cytokines, promoting cell survival and proliferation.
* **JAK/STAT pathway:** Activated by cytokines, promoting hepatocyte proliferation and differentiation.
**Regulation:**
* **Cell cycle control:** Hepatocyte proliferation is tightly regulated by checkpoints within the cell cycle, ensuring proper DNA replication and cell division.
* **Contact inhibition:** When cells reach a certain density, they cease proliferation, preventing uncontrolled growth.
* **Tissue microenvironment:** The extracellular matrix, cell-cell interactions, and other components of the liver microenvironment play a role in regulating hepatocyte proliferation.
* **Liver-specific microRNAs:** These small non-coding RNAs regulate gene expression, influencing hepatocyte proliferation and differentiation.
**Consequences of Dysregulation:**
* **Liver regeneration failure:** Inadequate proliferation can impair liver regeneration after injury, leading to liver failure.
* **Liver cancer:** Uncontrolled hepatocyte proliferation can contribute to the development of liver cancer.
**Therapeutic Implications:**
* **Promoting hepatocyte proliferation:** HGF and other growth factors are being investigated for therapeutic use in liver regeneration.
* **Inhibiting hepatocyte proliferation:** Targeting specific pathways or transcription factors involved in hepatocyte proliferation may be useful in treating liver cancer.'
"
Protein | Definition | Taxonomy |
---|---|---|
Zinc finger protein GLI1 | A zinc finger protein GLI1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P08151] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
staurosporine aglycone | staurosporine aglycone: metabolite from culture broth of Nocardiopsis sp.; a neurotrophin antag; inhibits BDNF TrkB receptor | ||
betulinic acid | hydroxy monocarboxylic acid; pentacyclic triterpenoid | anti-HIV agent; anti-inflammatory agent; antimalarial; antineoplastic agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; plant metabolite | |
ceanothic acid | ceanothic acid: isolated from Ceanothus americanus; structure in first source | ||
gant 61 | GANT 61: a sonic hedgehog pathway inhibitor and Gli inhibitor; structure in first source GANT61 : An aminal that is hexahydropyrimidine which is substituted on each nitrogen by a 2-(dimethylamino)benzyl group, and at the aminal carbon by a pyridin-4-yl group. A Hedgehog signaling pathway and Gli protein inhibitor. | aminal; dialkylarylamine; pyridines; substituted aniline; tertiary amino compound | antineoplastic agent; apoptosis inducer; glioma-associated oncogene inhibitor; Hedgehog signaling pathway inhibitor |
zerumbone | zerumbone : A sesquiterpenoid and cyclic ketone that is (1E,4E,8E)-alpha-humulene which is substituted by an oxo group at the carbon atom attached to two double bonds. It is obtained by steam distillation from a type of edible ginger, Zingiber zerumbet Smith, grown particularly in southeast Asia. zerumbone: RN given for (E,E,E)-isomer; structure in first source | cyclic ketone; sesquiterpenoid | anti-inflammatory agent; glioma-associated oncogene inhibitor; plant metabolite |
nsc-287088 | |||
2alpha,3beta-dihydroxy-20(29)-lupen-28-oic acid | 2alpha,3beta-dihydroxy-20(29)-lupen-28-oic acid : A pentacyclic triterpenoid that is betulinic acid carrying an additional alpha-hydroxy group at position 2. It has been isolated from Breynia fruticosa. alphitolic acid: from the aerial parts of Gouania longipetala; structure in first source | dihydroxy monocarboxylic acid; pentacyclic triterpenoid | plant metabolite |
physalin f | physalin F : A physalin with antimalarial and antitumour activities isolated from Physalis angulata. physalin F: has immunosuppressive activity; from Physalis angulata L; structure given in first source | enone; epoxy steroid; lactone; physalin | antileishmanial agent; antimalarial; antineoplastic agent; apoptosis inducer; immunosuppressive agent |